{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:46:25Z","timestamp":1792122385583,"version":"4.4.0"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3201\/eid2207.151694","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T08:43:30Z","timestamp":1467362610000},"source":"Crossref","is-referenced-by-count":155,"title":["Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States"],"prefix":"10.3201","volume":"22","author":[{"given":"Andrew","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Molins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schriefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2207.151694-201607010841-R1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis.","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"key-10.3201\/eid2207.151694-201607010841-R2","unstructured":"Pritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP, Identification of a novel pathogenic\n                      Borrelia\n                      species causing Lyme borreliosis with unusually high spirochataemia: a descriptive study. Lancet Infect Dis. 2016;Feb 5:pii: S1473-3099(15)00464-8."},{"key":"key-10.3201\/eid2207.151694-201607010841-R3","first-page":"1","article-title":"Summary of notifiable diseases\u2014United States, 2012.","volume":"61","author":"Adams","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2207.151694-201607010841-R4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010.","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3201\/eid2108.141878","article-title":"Geographic distribution and expansion of human Lyme disease, United States.","volume":"21","author":"Kugeler","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R7","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on serologic diagnosis of Lyme disease.","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2207.151694-201607010841-R8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00006454-199609000-00003","article-title":"Misdiagnosis of Lyme disease: when not to order serologic tests.","volume":"15","author":"Seltzer","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2207.151694-201607010841-R9","unstructured":"Centers for Disease Control and Prevention. Notice to readers: caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep. 2005;54:125 [cited 2016 Mar 14]. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5405a6.htm"},{"key":"key-10.3201\/eid2207.151694-201607010841-R10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis.","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2207.151694-201607010841-R11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3201\/eid0202.960211","article-title":"Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.","volume":"2","author":"Craven","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.","volume":"53","author":"Branda","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R14","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for Lyme disease diagnostic test development and evaluation.","volume":"52","author":"Molins","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R15","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1128\/JCM.01853-13","article-title":"Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of Lyme disease with noncutaneous manifestations.","volume":"51","author":"Wormser","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R16","unstructured":"Food and Drug Administration. Database: search on product code LSR [cited 2015 Jul 17]. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/devicesatfda\/index.cfm"},{"key":"key-10.3201\/eid2207.151694-201607010841-R17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1086\/374395","article-title":"Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.","volume":"187","author":"Bacon","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R18","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","article-title":"Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE.","volume":"37","author":"Liang","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.34.1.1-9.1996","article-title":"Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.","volume":"34","author":"Aguero-Rosenfeld","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jamainternmed.2014.5426","article-title":"Neoplasms misdiagnosed as \u201cchronic Lyme disease.\u201d","volume":"175","author":"Nelson","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key-10.3201\/eid2207.151694-201607010841-R21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/infdis\/161.6.1203","article-title":"Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis.","volume":"161","author":"Steere","year":"1990","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.diagmicrobio.2008.08.016","article-title":"Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue.","volume":"62","author":"Babady","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1086\/321911","article-title":"False-positive results of PCR testing for Lyme disease.","volume":"33","author":"Molloy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/infdis\/174.3.623","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.","volume":"174","author":"Nocton","year":"1996","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7326\/M15-0333","article-title":"Borrelia miyamotoi disease in the northeastern United States: a case series.","volume":"163","author":"Molloy","year":"2015","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2207.151694-201607010841-R26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0002-9343(99)00046-7","article-title":"Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States.","volume":"106","author":"Hilton","year":"1999","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2207.151694-201607010841-R27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease.","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1086\/521256","article-title":"Reinfection in patients with Lyme disease.","volume":"45","author":"Nadelman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R29","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/cid\/civ584","article-title":"Poor positive predictive value of Lyme disease serologic testing in an area of low disease incidence.","volume":"61","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.idc.2007.12.010","article-title":"STARI, or Masters disease: Lone Star tick\u2013vectored Lyme-like illness.","volume":"22","author":"Masters","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.3201\/eid2207.151694-201607010841-R31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ttbdis.2015.06.005","article-title":"Epidemiology of Lyme disease in low-incidence states.","volume":"6","author":"Forrester","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0002-9343(02)01440-7","article-title":"Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease.","volume":"114","author":"Steere","year":"2003","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2207.151694-201607010841-R33","first-page":"333.","article-title":"Concerns regarding a new culture method for Borrelia burgdorferi not approved for the diagnosis of Lyme disease.","volume":"63","author":"Nelson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2207.151694-201607010841-R34","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/cid\/ciu703","article-title":"A comparison of Lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment.","volume":"59","author":"Fallon","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1128\/JCM.01674-13","article-title":"Assessment of new culture method for detection of Borrelia species from serum of Lyme disease patients.","volume":"52","author":"Johnson","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9343(00)00701-4","article-title":"Intralaboratory reliability of serologic and urine testing for Lyme disease.","volume":"110","author":"Klempner","year":"2001","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2207.151694-201607010841-R37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1128\/CVI.00167-09","article-title":"Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls.","volume":"16","author":"Marques","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.3201\/eid2207.151694-201607010841-R38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/cid\/civ185","article-title":"Development of a metabolic biosignature for detection of early Lyme disease.","volume":"60","author":"Molins","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.151694-201607010841-R39","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1074\/mcp.M114.046540","article-title":"Discovery and targeted proteomics on cutaneous biopsies infected by Borrelia to investigate Lyme disease.","volume":"14","author":"Schnell","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"key-10.3201\/eid2207.151694-201607010841-R40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1128\/CVI.00245-14","article-title":"Simple objective detection of human Lyme disease infection using immuno-PCR and a single recombinant hybrid antigen.","volume":"21","author":"Halpern","year":"2014","journal-title":"Clin Vaccine Immunol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/7\/15-1694_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:27:23Z","timestamp":1732904843000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/7\/15-1694_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2207.151694","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}